Waystar Considers Sale Amidst Declining Market Value

Waystar, a prominent healthcare software provider, is reportedly exploring strategic options, including a potential sale. This move comes just two years after the company's public listing in New York. According to seven sources familiar with the matter, the company has engaged investment bank Evercore to guide the process, which remains in its preliminary stages.

Possible Sale on the Horizon

Based in Lehi, Utah, and Louisville, Kentucky, Waystar is known for its software that facilitates payment management for hospitals and doctors. The company's market value has plummeted to approximately $4.8 billion following a 24% drop in share price this year, reflecting broader declines in the software sector. This downturn has prompted Waystar to consider whether a sale might be a viable path forward.

Waystar's strategic positioning as a healthcare software provider, rather than a service-based business, was designed to attract the higher valuations typical of tech companies. Initially, this approach was successful, with shares climbing from $20 to a peak of $45 in 2025. However, investor concerns over the potential impact of advancements in artificial intelligence on software companies have since pressured the stock.

Ownership and Investment Landscape

Waystar was created in 2017 through the merger of Zirmed and Navicure, two healthcare revenue management firms. Its major shareholders include EQT, the Canada Pension Plan Investment Board (CPPIB), and Bain Capital. EQT holds the largest stake at 13%, followed by CPPIB at 10% and BlackRock Institutional Trust Company at 8%, according to data from LSEG.

The company's decision to potentially revert to private hands could be influenced by its current shareholders and their strategic objectives. EQT, CPPIB, and BlackRock have so far declined to comment on the speculation surrounding Waystar's future.

Market Context and Future Prospects

The healthcare software sector has faced volatility, partly due to technological advancements and changing investor sentiment. Analysts at Morgan Stanley highlighted in a July report that the rise of artificial intelligence presents both opportunities and challenges for companies like Waystar.

As the company navigates these challenges, the involvement of Evercore suggests a structured approach to evaluating its options. While a sale is under consideration, sources caution that plans are not final and could change. The potential auction process may also test investor interest in software companies amid the current market conditions.

Waystar and Evercore have not provided comments on the ongoing developments. The exploration of a sale reflects broader industry trends as companies reassess their market positions and growth strategies in a rapidly evolving landscape.